title: Prevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, India.
abstract: To study the prevalence of metabolic syndrome (MS) among newly diagnosed hypertensive patients in a tertiary care hospital in the northern hilly state of Himachal Pradesh, India, located in western Himalayas at a moderate altitude of 2200 m above mean sea level. One hundred and eighteen newly diagnosed hypertensive patients above the age of 20 years were studied in a hospital-based cross-sectional study. MS prevalence was estimated by International Diabetes Federation (IDF) criteria and modified National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria. Student's t-test was used to compare the mean of the continuous variables. Chi-square test was used to compare discrete variables. The prevalence of MS in hypertensive patients was 68.6% (modified NCEP-ATP III) and 63.6% (IDF criteria). The most common phenotype of MS with the component of hypertension was the coexistence of waist circumference (90.1%), low high-density lipoprotein (HDL; 70.4%), and high triglycerides (67.9%) as per the modified NCEP-ATP III criteria, and low HDL (76.2%) and high triglycerides (66.4%) as per the IDF criteria. Fasting blood glucose (33.2% as per the modified NCEP-ATP III criteria and 32.6% as per the IDF criteria) was the least significant factor having an association with MS. The prevalence of MS among hypertensive patients was high and indicates the need for metabolic screening in all hypertensive patients at the first diagnosis.
authors: Department of Medicine, Dr. Rajendra Prasad Govt. Medical College, Tanda Kangra, India.
authors: Surender
authors: S
authors: Thakur
authors: Sujeet
authors: S
authors: Raina
authors: Surinder
authors: S
authors: Thakur
authors: Prakash C
authors: PC
authors: Negi
authors: Balbir S
authors: BS
authors: Verma
keywords: Hypertension; India; metabolic syndrome; moderate altitude; western Himalayas
references: Med Clin (Barc). 2006 Mar 25;126(11):406-9
references: 16595083
references: J Intern Med. 1999 Feb;245(2):163-74
references: 10081519
references: Diabetes Care. 2007 Jun;30(6):1624-6
references: 17351284
references: J Hum Hypertens. 2007 Sep;21(9):729-35
references: 17525708
references: Ann Acad Med Singap. 2005 Apr;34(3):243-9
references: 15902345
references: J Assoc Physicians India. 2012 Jun;60:21-5
references: 23409416
references: J Hypertens. 1995 Oct;13(10):1193-200
references: 8586811
references: Diabetes Obes Metab. 2007 Jan;9(1):50-8
references: 17199718
references: J Hypertens. 2008 Oct;26(10):2064-70
references: 18806632
references: Metab Syndr Relat Disord. 2007 Spring;5(1):55-62
references: 18370814
references: J Am Coll Cardiol. 2004 May 19;43(10):1817-22
references: 15145106
references: J Hum Hypertens. 1997 Oct;11(10):679-85
references: 9400911
references: J Assoc Physicians India. 2007 May;55:326-32
references: 17844691
references: Lancet. 2005 Jan 15-21;365(9455):217-23
references: 15652604
references: J Intern Med. 2005 May;257(5):454-60
references: 15836662
references: J Assoc Physicians India. 2003 Jan;51:20-7
references: 12693449
references: Int J Cardiol. 2013 Jul 1;166(3):633-9
references: 22192283
references: J Intern Med. 2005 Jun;257(6):503-13
references: 15910554
references: Indian Heart J. 1990 Sep-Oct;42(5):375-9
references: 2086444
references: High Alt Med Biol. 2006 Fall;7(3):245-55
references: 16978137
references: Cardiovasc Diabetol. 2009 Sep 15;8:51
references: 19754934
references: J Hum Hypertens. 2004 Feb;18(2):73-8
references: 14730320
references: Circulation. 2005 Oct 25;112(17):2735-52
references: 16157765
references: Clin Med Res. 2011 Mar;9(1):26-31
references: 20682756
references: Med Princ Pract. 2004 Jan-Feb;13(1):39-42
references: 14657618
references: Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1:S104-9
references: 22701827